In December 2017 the International Equestrian Federation (FEI) has reported an anti-doping rule violation against the American rider Hanna Burnett (21) after her A and B samples tested positive for the prohibited substance Amphetamine. After notification the Athlete gave a prompt admission, accepted a provisional suspension, waived her right to be heard and filed a statement in her defence.
The Athlete explained that she had used prescribed medication as treatment for her ADHD. Her request for a Retroactive TUE was denied, her application for a prospective TUE was approved in April 2018.
In May 2018 the parties in this case reached an agreement for approval into a decision of the FEI Tribunal.
The parties agree that the Athlete established No Significant Fault or Negligence, that the violation was not intentional and that a 1 year period of ineligibility is imposed on the Athlete starting on the date of the sample collection, i.e. 18 November 2017.
Further a CHF 1,500 fine is imposed on the Athlete with disqualification of her results. The Athlete agrees to support the FEI in its ant-doping campaing and to actively engage in Athlete education around human anti-doping.
On 25 May 2018 the FEI Tribunal decides to ratify the Agreement between the FEI and the Athlete with the consent of the Parties.
